Immune-mediated inner-ear disease includes clinical conditions associated w
ith unilateral or bilateral rapidly progressive forms of sensorineural hear
ing loss. A systemic autoimmune disorder can be present in less than one-th
ird of cases.
Because of the lack of well defined detection methods to identify immune-me
diated processes within the inner ear, and the fact that the human inner ea
r is not amenable to diagnostic biopsy, there has been great interest in de
veloping animal models. Experimental models of sterile and virus-induced la
byrinthitis support the participation of the immune system in the aetiopath
ogenesis of inner-ear disorders: interleukin-2 emanates from the endolympha
tic sac and assists in changing the spiral modiolar vein, as in the express
ion of intercellular adhesion molecule 1, which allows the egress of immune
cells from the circulation. The formation of a fibro-osseous matrix ultima
tely results in degeneration of the inner ear.
These investigations have allowed us to alter the immune response for the p
urpose of regulating its intensity and the subsequent damage to patients.